Straumann 

€9.50
90
-€0.05-0.52% 13:33 Today

Statistics

Day High
9.65
Day Low
9.55
52W High
11.4
52W Low
7.3
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.13%
Dividend
0.11

Upcoming

Dividends

1.13%Dividend Yield
May 26
€0.11
May 25
€0.03
May 25
€0.06
May 24
€0.04
May 24
€0.05
10Y Growth
11.63%
5Y Growth
15.92%
3Y Growth
10.35%
1Y Growth
75.2%

Earnings

19AugExpected
Q4 2025
Q2 2026
1.42
1.53
1.63
1.74
Expected EPS
1.69168655187756
Actual EPS
1.7378671935199999

Financials

13.65%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.79BRevenue
381.38MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QS50.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Henry Schein
HSIC
Mkt Cap9.98B
Henry Schein distributes dental products and services, including dental reconstructive products, competing directly with Straumann's dental implants and prosthetics.
DENTSPLY Sirona
XRAY
Mkt Cap2.22B
Dentsply Sirona is a direct competitor in the dental supplies market, offering a wide range of dental products including dental implants and prosthetic solutions.
Align Technology
ALGN
Mkt Cap11.19B
Align Technology, known for its Invisalign system, competes in the dental market by offering orthodontic products that can be alternatives to traditional braces and, indirectly, to dental implants.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, while primarily focused on orthopedic reconstructive devices, also offers dental implant and related products, competing in the dental implant market.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew, known for its advanced wound management, orthopedics, and other medical devices, competes indirectly by offering products in the reconstructive space, including dental.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation, a leader in medical technology, offers a range of products that compete in the orthopedics market, which can indirectly affect the market for dental implants and reconstructive solutions.
Danaher
DHR
Mkt Cap151.89B
Danaher Corporation, through its dental segment, provides a broad portfolio of dental products, including dental implants and consumables, directly competing with Straumann.
3M
MMM
Mkt Cap89.91B
3M, through its Health Care business, offers dental products and solutions, including dental adhesives and restoratives, indirectly competing with dental implants and prosthetics.
Envista
NVST
Mkt Cap4.36B
Envista Holdings Corporation, spun off from Danaher, operates in the dental products sector, offering comprehensive dental solutions that compete with Straumann's offerings.

About

Straumann Holding AG is a leading global provider of comprehensive dental solutions, specializing in tooth restoration, replacement, and orthodontic treatment. The company actively engages in the research, development, production, and distribution of a diverse portfolio of dental products. This range encompasses advanced dental implants, precision instruments, CAD/CAM prosthetics, clear orthodontic aligners, biomaterials, and cutting-edge digital technologies. These offerings are designed to facilitate tooth correction, replacement, and restoration, while also playing a role in preventing future tooth loss. Straumann's core product lines include a wide array of dental implant systems, featuring tissue and bone level options crafted from materials like titanium, titanium alloy, and ceramics, alongside specialized mini-implants. The company also supplies a full suite of surgical instruments, both guided and non-guided, vital for implant procedures, as well as various implant-supported prosthetics. It excels in digital dentistry, offering sophisticated intraoral scanning solutions, 3D printers, and milling machines. Complementing these are ceramic healing and screw-retained abutments, and a selection of preventative oral care products. A significant part of its portfolio is dedicated to biomaterials, including bone substitutes, specialized membranes, biologics, and products for soft tissue management and enhanced oral healing. Digital solutions extend to dental laboratories, clinics, and central milling facilities, supported by a range of materials, third-party system integrations, and guided surgery technologies. Its comprehensive surgical instrument catalog features modular and specialized cassettes, implant maintenance tools, bone block fixation sets, bonerings, and titanium pin sets. For patients with complete tooth loss (edentulous patients), Straumann provides specialized solutions like pro arch fixed prosthetics and mini implant systems. The company also focuses on aesthetic restorations, offering ceramic implant monotypes, ceramic implants, and various abutments, often enhanced by biologics. Its offerings further include the Clear Correct aligner system for orthodontic correction, and Emdogain, a product designed for wound healing. Beyond products, Straumann is committed to professional development, providing extensive training and educational services to its client base. Straumann's diverse clientele includes general dentists, dental specialists, and technicians working in laboratories. It also serves corporate entities such as distributors, hospitals, universities, and large dental service organizations. Its products reach customers in approximately 100 countries, facilitated by a robust network of direct distribution subsidiaries and strategic partners. Established in 1954, Straumann Holding AG maintains its corporate headquarters in Basel, Switzerland.
Show more...
CEO
Guillaume Daniellot
Employees
11824
Country
Switzerland
ISIN
US86317T1034
WKN
000A2QPJX

Listings

0 Comments

Share your thoughts

FAQ

What is Straumann stock price today?
The current price of QS50.STU is €9.50 EUR — it has decreased by -0.52% in the past 24 hours. Watch Straumann stock price performance more closely on the chart.
What is Straumann stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Straumann stocks are traded under the ticker QS50.STU.
Is Straumann stock price growing?
QS50.STU stock has risen by +1.6% compared to the previous week, the month change is a -10.75% fall, over the last year Straumann has showed a +2.69% increase.
When is the next Straumann earnings date?
Straumann is going to release the next earnings report on February 24, 2027.
What were Straumann earnings last quarter?
QS50.STU earnings for the last quarter are 1.74 EUR per share, whereas the estimation was 1.69 EUR resulting in a +2.73% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Straumann revenue for the last year?
Straumann revenue for the last year amounts to 2.79B EUR.
What is Straumann net income for the last year?
QS50.STU net income for the last year is 381.38M EUR.
Does Straumann pay dividends?
Yes, QS50.STU dividends are paid annual. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (FWD)% is 1.13%.
How many employees does Straumann have?
As of September 04, 2026, the company has 11,824 employees.
In which sector is Straumann located?
Straumann operates in the Health & Wellness sector.
When did Straumann complete a stock split?
The last stock split for Straumann was on April 28, 2022 with a ratio of 5:1.
Where is Straumann headquartered?
Straumann is headquartered in Basel, Switzerland.